Platte River Capital’s Enzo Biochem, Inc. ENZ Stock Holding History

Platte River Capital’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$100K	Sell	31,500 -83,957	-73%	-$255K	0.09%	116
2015 Q2	$350K	Sell	115,457 -6,583	-5%	-$18.5K	0.18%	127
2015 Q1	$360K	Buy	122,040 +94,130	+337%	+$308K	0.16%	121
2014 Q4	$124K	Sell	27,910 -198,950	-88%	-$949K	0.05%	164
2014 Q3	$1.17M	Sell	226,860 -125,250	-36%	-$668K	0.3%	100
2014 Q2	$1.85M	Sell	352,110 -118,890	-25%	-$514K	0.28%	102
2014 Q1	$1.96M	Sell	471,000 -60,000	-11%	-$206K	0.27%	117
2013 Q4	$1.55M	Buy	+531,000	New	+$1.32M	0.2%	133

Other funds holding ENZ

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

LSVM

Lone Star Value Management Old Greenwich, Connecticut $52.7M AUM 30.18% 1-Year Est. Return

KIA

Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

MAG

Millrace Asset Group Berwyn, Pennsylvania $98.4M AUM 63.71% 1-Year Est. Return

Platte River Capital's ENZ Position: Q3 2015 in Review

Platte River Capital reduced its Enzo Biochem, Inc. (ENZ) stake by 73% in Q3 2015, selling an estimated $255K and leaving 31,500 shares worth $100K. The position accounts for 0.09% of the portfolio, ranked #116.

Platte River Capital first reported a position in ENZ in Q4 2013 and has held it in 8 quarters since. The position peaked at $1.96M in Q1 2014. 82 funds tracked by Wall St. Rank hold ENZ as of Q3 2015.

Platte River Capital held 31,500 shares of Enzo Biochem, Inc. worth $100K as of Q3 2015.
Platte River Capital sold 83,957 Enzo Biochem, Inc. shares in Q3 2015, an estimated $255K.
Enzo Biochem, Inc. made up 0.09% of Platte River Capital's portfolio in Q3 2015, its #116 holding.
Platte River Capital first reported a position in Enzo Biochem, Inc. in Q4 2013 and has held it in 8 quarters since.
Platte River Capital's Enzo Biochem, Inc. position peaked at $1.96M in Q1 2014.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2015.

Based on Platte River Capital's 13F filing for Q3 2015, filed 12 Nov 2015.